Medicine

All Articles

Prenatal exposure to destitution influences long-lasting health and wellness

.Attribute Medication, Released online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis of...

A global metric of immune wellness

.Attribute Medication, Published online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A research...

Niacin, food items consumption and cardio impacts

.Attributes Medication, Released online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, fo...

Opportunities as well as difficulties for patient-reported result examination in multimorbidity study and strategy

.Contending rate of interests.S.E.H. receives funding from the National Principle of Health And Well...

Hibernation science harnessed to handle weight problems and also change rate of metabolism

.Attributes Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy understandi...

CAR- T as well as cellular genetics treatments are also expensive

.Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care p...

The WHO genomics system of benefit reasonable application of human genomics for worldwide health and wellness

.The magazine of the initial draft of the human genome pattern in 20011 was actually observed due to...

A time-stratified, case\u00e2 $ \"crossover research of heat direct exposure and also perinatal mortality coming from 16 medical facilities in sub-Saharan Africa

.Among 138,015 hospital-based singleton childbirths in four sub-Saharan African countries, our compa...

Advancing international antibiotic research study, advancement and also access #.\n\nMurray, C. J. L. et cetera. International problem of bacterial antimicrobial resistance in 2019: an organized analysis. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Leaders. Towards specific dedications as well as action in the action to antimicrobial protection. Global Leaders Team on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). World Wellness Institution. That releases list of germs for which brand-new prescription antibiotics are urgently required. Planet Health Association https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). World Health Company. That bacterial concern microorganisms listing, 2024: microbial virus of public health value to direct research, advancement as well as techniques to prevent as well as manage antimicrobial resistance. Globe Health and wellness Association https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entrance. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nWorld Wellness Organization. 2023 anti-bacterial representatives in scientific and also preclinical advancement: a review and study. Planet Wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Assessment. May 19, 2016 \u00e2 $\" Handling drug-resistant diseases worldwide: last document and suggestions. Review on Antimicrobial Protection https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Consortium. DRIVE-AB outcomes: files and briefing. Steer abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall structure: a require concurrent activity on prescription antibiotics trial and error. Boston Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Concise 51: Just how can the EU support lasting advancement and accessibility to successful antibiotics? policy choices for existing and brand new medications. International Observatory on Health Units and also Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Anti-biotic use and resistance\u00e2 $\" showing the obvious. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Wellness Association. 2021 Informed classification. WHO get access to, watch, reserve, category of anti-biotics for evaluation as well as tracking of use. Globe Health Organization https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Facility for Condition Protection and Management. Antimicrobial protection aim ats: exactly how can our experts reach them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). World Health And Wellness Association. Shortage of advancement set to threaten antibiotic functionality and also health and wellness gains. Planet Health and wellness Organization https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Exactly how antimicrobial resistance is actually connected to environment adjustment: an outline of two intertwined worldwide obstacles. Int. J. Environ. Res. Public Health twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial contaminations: our company need to have important activity and investment that concentrate on the weakest hyperlink. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Health Organization. Immunization protection. World Wellness Institution https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Disease avoidance as well as management in low-resource setups: the demand for the regional, the contextual and the pragmatic. Affect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Obstacles of applying antimicrobial conservation devices in reduced to mid revenue nations (LMICs). Corrupt. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A brief history of the antibiotic time: sessions found out and difficulties for the future. Front end. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K. et cetera. Patient gain access to in 14 high-income countries to brand new antibacterials accepted due to the US Fda, European Medicines Firm, Japanese Pharmaceuticals as well as Medical Equipment Firm, or even Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Health Institution. 2021 antibacterial brokers in clinical as well as preclinical growth: a summary and also analysis. Globe Wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Prescription antibiotics: the economics should sustain the science. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of development in anti-bacterial therapies. Medical Development Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et al. Determining clinician utilization of next-generation anti-biotics versus resisting Gram-negative diseases in USA health centers: a retrospective cohort research. Ann. Trainee. Medication. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of advancement in antibacterial therapeutics. Medical Development Association https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A methodical review and also crucial analysis of motivation methods for exploration as well as advancement of unfamiliar anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle Scholar\u00c2.\nHealth And Wellness Urgent Preparedness and Reaction Authorization. Trial and error of clinical countermeasures. European Commission https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Percentage. Pre-draft proposal for an European relationship under Perspective Europe One Health And Wellness Antimicrobial Resistance. European Commission https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Antibiotic Trial And Error Collaboration. Entasis Therapeutics and the International Antibiotic Research &amp Progression Relationship to create a brand new treatment for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of field- as well as non-industry-sponsored professional tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Health And Wellness Institution. Amount of scientific test registrations by location, ailment, stage of progression, grow older as well as sex of test attendees (1999\u00e2 $ \"2022). Globe Wellness Association https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Global Prescription Antibiotic R &amp D Alliance. NeoSept1: a study to identify the position of existing and also brand-new antibiotics mixtures to address newborn babies who reside in healthcare facility with severe blood poisoning. ISRCTN registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Firm of Canada. Government of Canada makes crucial assets to combat antimicrobial protection (AMR), Government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Global Anti-biotic Experimentation Relationship. Asia federal government funding sustains GARDP\u00e2 $ s attempts to respond to antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Groundwork. Novo Nordisk Structure companions with CARB-X to eliminate drug-resistant infections. novo nordisk base https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health And Wellness and Digital Executive Company. Research study on carrying AMR medical countermeasures to the market. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Estimating the suitable dimension of worldwide pull rewards for antibacterial medicines. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entrance incentive for the growth of brand new prescription antibiotics. Harvard Kennedy Institution https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et cetera. Business motivations and antibiotic resistance: an intro to the antibiotic vulnerability perk. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An enthusiastic USG accelerated commitment for subscription-based investing in of unfamiliar antimicrobials and its own assumed return on investment. Center for Global Progression https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 investments in new anti-biotics would pay off \u00e2 $\" for every person. Office of Wellness Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS boosts battle against serious contaminations complying with prosperous world-first aviator. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Congress. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Percentage. Reform of the EU pharmaceutical legalisation. International Commission https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Reimbursement designs to confront market failures for antimicrobials: methods taken in France, Germany, Sweden, the United Kingdom, as well as the USA. Health and wellness Policy 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Alliance of Pharmaceutical Manufacturers as well as Affiliations. From protection to durability: what could the future antibiotic pipeline seem like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Global AMR R&ampD Hub &amp Planet Health Company. Incentivising the growth of new antibacterial procedures: 2023 progress report due to the Global AMR R&ampD Center and WHO. Worldwide AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK registration version for anti-biotics looked at prosperous? Lancet Microorganism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimulations for the advancement and keeping on the marketplace of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, local, and national causes of kid death in 2000\u00e2 $ \"13, with projections to update post-2015 top priorities: an updated systematic evaluation. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et cetera. Anti-bacterial drug scarcities from 2001 to 2013: effects for medical training. Clin. Affect. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et cetera. The French coverage body for medication scarcities: explanation and also styles from 2012 to 2018: an empirical retrospective research. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et al. Analysis of that antibiotic usage and also access aim ats in 76 nations, 2000\u00e2 $ \"15: a study of pharmaceutical purchases data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Combating the fakes: addressing second-rate and falsified medications. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it acquiring simpler to get antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nBlack Community for Laboratory Medication. Plan brief as well as infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic consumption for individual use in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research. Trop. Medication. Corrupt. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial usage: analysis of core storehouses supplies to in-patient care health amenities coming from 2017 to 2019 in Uganda. Trop. Med. Infect. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et cetera. Variations in the usage of antimicrobial medicines in the International area, 2014\u00e2 $ \"2018: results and also ramifications from ESAC-Net as well as WHO Europe. Front end. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et al. Drug lack: reasons, impact, and also mitigation approaches. Face. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Patient accessibility in 14 high-income countries to new antibacterials permitted due to the United States Fda, European Medicines Organization, Japanese Pharmaceuticals as well as Medical Equipment Organization, or Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPulcini, C. et cetera. Wasted anti-biotics: a follow-up supply study in Europe, the U.S.A., Canada as well as Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness innovation for global wellness. Br. Med. J. 366, 15601 (2019 ).\nGoogle.com Scholar\u00c2.\nAMR Field Alliance. The 2023 AMR Industry Collaboration improvement poll: manufacturing as well as the environment. amr Sector Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can health care products be actually cultivated on a non-profit basis? Looking into item development relationships for ignored ailments. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et cetera. Restart biomedical R&ampD in the worldwide public interest. Attributes 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Illness Management and Deterrence. Africa CDC directs vibrant relocate to secure Africa\u00e2 $ s wellness future by creating a 50 billion dollar medical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Blood, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Arranging public-health patent licensing deals to boost accessibility to health innovations: an insider\u00e2 $ s story. BMJ Glob. Health 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New service styles for r &amp d along with cost requirements are needed to accomplish fair prices of medications. Br. Medication. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Accelerator. Stewardship and also access. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Global Anti-biotic R &amp D Relationship. Shinogi, GARDP as well as CHAI introduce landmark license as well as collaboration arrangements to manage microbial contaminations next to increasing accessibility to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Field Partnership. Leaving behind the laboratory: tracking the downtrend in AMR R&ampD experts. amr Market Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 contact us to action on antimicrobial resistance. G7G20 Documentations Data bank https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). International Coalition on Getting Older &amp Transmittable Health Conditions Society of The United States. 2024 AMR preparedness mark report card. Gauging federal government action on AMR plan. International Union on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items and Agriculture Organization of the United Nations, United Nations Atmosphere Program, World Wellness Company &amp. World Company for Creature Health And Wellness. Global database for tracking antimicrobial resistance (AMR): nation self-assessment study (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in th...

Integrating liver endpoints in clinical tests of cardio and also kidney disease

.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Stan...